Technology News and Research

RSS

HHS pumps up rhetoric but eases rules on health insurance for kids

Politico reports that the administration "is taking health insurers to task again, this time for choosing to no longer sell plans intended to cover sick children." Insurers "have said in recent weeks that they would stop selling 'child only' insurance plans because the overhaul requires them to accept all applicants, even if they apply for coverage at the last minute before treatment." In a letter to industry groups, Health and Human Services Secretary Kathleen Sebelius highlighted the "plight of millions of parents who desperately want to provide health coverage and critical treatments" in the face of insurer decisions.

28 Sep 2010

IAVI investigators awarded grant to examine antibodies that neutralize HIV virus

A team of investigators headed by International AIDS Vaccine Initiative Investigator Pascal Poignard has been awarded a major grant from the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health to investigate the biological mechanisms underlying the generation of broadly neutralizing antibodies by HIV positive individuals.

28 Sep 2010

Government health IT market poised to grow dramatically

The Washington Post reports on the growing field of government health IT jobs.

28 Sep 2010

Genomics obtains worldwide rights to The Garvan Institute of Medical Research's methylation DNA biomarkers

Clinical Genomics Pty. Ltd (Sydney, Australia) and The Garvan Institute of Medical Research (Sydney, Australia) today announced that they have entered into a license agreement in relation to novel biomarkers discovered by scientists at the Garvan Institute. Under the terms of the agreement, Clinical Genomics obtains worldwide exclusive rights to the Garvan's proprietary cancer associated methylation DNA biomarkers for the diagnosis and or treatment of colorectal cancer.

28 Sep 2010

DecImmune Therapeutics receives funds to improve ischemia reperfusion injury outcomes

DecImmune Therapeutics announced today that it has received a $1 million equity investment from Astellas Venture Management and has additionally been awarded $2.2 million in Phase II SBIR funding from the National Institutes of Health.

28 Sep 2010

Guided Therapeutics files PMA for LightTouch Cervical Scanner

Guided Therapeutics, Inc. announced that it filed its completed premarket approval application (PMA) for the LightTouch Cervical Scanner with the U.S. Food and Drug Administration (FDA) for patients at risk for cervical cancer.

28 Sep 2010

KeyVive provides Simplatype mHealth SMS technology to improve healthcare

KeyVive, Inc., a healthcare technology company that uses social media and self management tools to help individuals with chronic illnesses, is dialing up a ground-breaking, HIPAA compliant mHealth technology for people not only affected by diabetes, but also with other diseases.

28 Sep 2010

ATSC to provide software development services for NCI

ATS Corporation, a leading information technology company that delivers innovative technology solutions to government and commercial organizations, today announced that it has been awarded a new contract totaling $13.3 million over a five-year term with the National Cancer Institute.

28 Sep 2010

Rockland receives Phase I SBIR grant to develop assay for monitoring Akt pathway activity

Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop a pharmacodynamic assay to monitor the Akt/mTOR signaling pathway.

28 Sep 2010

Sanofi Pasteur signs agreement to acquire VaxDesign

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group announced today that it has signed a binding agreement for the acquisition of VaxDesign, a privately held U.S. biotechnology company, based in Orlando, Florida, that develops, manufactures and markets in vitro models of the human immune system.

28 Sep 2010

UGA researcher receives NIH award for high-risk, high-reward carbohydrate research

The National Institutes of Health has awarded a prestigious EUREKA award to Robert Woods, a professor at the University of Georgia Complex Carbohydrate Research Center, to develop a new method for understanding how antibodies interact with large molecules known as glycans that are a major component of all cell surfaces.

27 Sep 2010

UCLA develops educational program to train U.S. armed forces in critical combat casualty care

With American troops leaving Iraq and military efforts continuing in Afghanistan, UCLA has helped develop a first-of-its-kind educational program to train U.S. armed forces medical personnel in critical combat casualty care. The program will not only help advance military care, the program's developers say, but civilian care as well.

27 Sep 2010

OrSense introduces NBM200 system for anemia screening, hemorrhage detection

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced at the Global Forum of Maternal and Infant Health, at Barcelona, Spain, NBM200, a non-invasive hemoglobin measurement system for anemia screening and hemorrhage detection. The Company presented results showing that Hb measurements obtained by the NBM200 showed accurate performance compared with invasive point of care devices.

27 Sep 2010

Chem Rx reaches asset purchase agreement with PharMerica

Chem Rx Corporation, the third largest long-term care pharmacy in the United States, today announced that it has reached a "stalking horse" asset purchase agreement to sell substantially all of the assets of the company to PharMerica Corporation, an industry-leading pharmaceutical services company serving residents in long-term facilities and settings.

27 Sep 2010

Researchers identify cellular/molecular defect in T cell regulatory pathway

Researchers at Columbia University Medical Center have identified a defect in the T cell regulatory pathway which normally controls autoreactive T cells that attack the body's own tissues and organs. A majority of people with Type 1 diabetes who were tested in the study were found to have the newly-identified cellular/molecular defect, and the researchers were able to successfully correct the defect in-vitro.

27 Sep 2010

Parascript receives CE Mark for AccuDetect software

Parascript, LLC, the image analysis and pattern recognition technology provider, today announced that it received CE (Conformite Europeenne) Mark for AccuDetect Galileo Computer Aided Detection (CAD) software.

27 Sep 2010

Clinical trial results of Genous Bio-engineered R stent, EPC capture technology presented at TCT 2010

OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.

27 Sep 2010

Technology News and Research

HHS pumps up rhetoric but eases rules on health insurance for kids

IAVI investigators awarded grant to examine antibodies that neutralize HIV virus

Government health IT market poised to grow dramatically

Genomics obtains worldwide rights to The Garvan Institute of Medical Research's methylation DNA biomarkers

DecImmune Therapeutics receives funds to improve ischemia reperfusion injury outcomes

Guided Therapeutics files PMA for LightTouch Cervical Scanner

KeyVive provides Simplatype mHealth SMS technology to improve healthcare

ATSC to provide software development services for NCI

Rockland receives Phase I SBIR grant to develop assay for monitoring Akt pathway activity

Sanofi Pasteur signs agreement to acquire VaxDesign

UGA researcher receives NIH award for high-risk, high-reward carbohydrate research

UCLA develops educational program to train U.S. armed forces in critical combat casualty care

OrSense introduces NBM200 system for anemia screening, hemorrhage detection

Chem Rx reaches asset purchase agreement with PharMerica

Researchers identify cellular/molecular defect in T cell regulatory pathway

Parascript receives CE Mark for AccuDetect software

Clinical trial results of Genous Bio-engineered R stent, EPC capture technology presented at TCT 2010

ARTES acquires ANAVAX virus-like particle technology from Select Vaccines

Progenika receives CE Mark approval to market LPLchip in Europe

Boston releases HORIZONS-AMI trial data

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News